BIOGYBIOGYOTC
Loading
Cash Flow Under PressureContracting
Percentile Rank79
3Y CAGR+0.2%
5Y CAGR+8.1%
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

3Y CAGR
+0.2%/yr
vs +15.4%/yr prior
5Y CAGR
+8.1%/yr
Recent deceleration
Acceleration
-15.2pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$302.97M-15.6%
2024$359.06M-4.8%
2023$377.25M+25.3%
2022$301.03M+39.7%
2021$215.50M+5.0%
2020$205.18M+88.5%
2019$108.83M-35.9%
2018$169.67M-13.4%
2017$195.99M+37.7%
2016$142.32M-